Clinical Trial Update: Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia [Phase 3]

View source ↗

Summary

This entry provides a Phase 3 clinical trial protocol update for Interfant-21 in infants under 1 year with KMT2A-rearranged acute lymphoblastic leukemia or mixe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Mixed Phenotype Acute Leukemia

Snippet

Sponsor: Princess Maxima Center for Pediatric Oncology | Conditions: Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia | Phase 3 | Status: RECRUITING